Publication:
Oncogenic Rag GTPase signaling enhances B cell activation and drives follicular lymphoma sensitive to pharmacological inhibition of mTOR.

dc.contributor.authorOrtega-Molina, Ana
dc.contributor.authorDeleyto-Seldas, Nerea
dc.contributor.authorCarreras, Joaquim
dc.contributor.authorSanz, Alba
dc.contributor.authorLebrero-Fernández, Cristina
dc.contributor.authorMenéndez, Camino
dc.contributor.authorVandenberg, Andrew
dc.contributor.authorFernández-Ruiz, Beatriz
dc.contributor.authorMarín-Arraiza, Leyre
dc.contributor.authorde la Calle Arregui, Celia
dc.contributor.authorBelén Plata-Gómez, Ana
dc.contributor.authorCaleiras, Eduardo
dc.contributor.authorde Martino, Alba
dc.contributor.authorMartínez-Martín, Nuria
dc.contributor.authorTroulé, Kevin
dc.contributor.authorPiñeiro-Yáñez, Elena
dc.contributor.authorNakamura, Naoya
dc.contributor.authorAraf, Shamzah
dc.contributor.authorVictora, Gabriel D
dc.contributor.authorOkosun, Jessica
dc.contributor.authorFitzgibbon, Jude
dc.contributor.authorEfeyan, Alejo
dc.contributor.funderMiniterio de Innovación, Ciencia y Universidades (España)
dc.contributor.funderEU-H2020 Programme
dc.date.accessioned2025-01-31T12:35:34Z
dc.date.available2025-01-31T12:35:34Z
dc.date.issued2019-08
dc.descriptionWe are indebted to D. M. Sabatini (R01 CA129105, R01 CA103866 and R37 AI047389) and thank R. Jaenisch, S. Markoulaki and the Whitehead Institute for Biomedical Research CRISPR facility for zygote injections. We thank A. Clear and K. Korfi for generating TMAs from lymphoma patients, and P. A. Katajisto for critical reading of the manuscript. We also thank CNIO Flow Cytometry, Histopathology, Animal Facility and Genomics Core Units for excellent technical support. Research was supported by the RETOS projects Programme of Spanish Ministry of Science, Innovation and Universities, Spanish State Research Agency, cofunded by the European Regional Development Fund (grant SAF2015-67538-R), EU-H2020 Programme (ERC-2014-STG-638891), Excellence Network Grant from MICIU/AEI (SAF2016-81975-REDT), a Ramon y Cajal Award from MICIU/AEI (RYC-2013-13546), Spanish Association Against Cancer Research Scientific Foundation Laboratory Grant, Beca de Investigacion en Oncologia Olivia Roddom, FERO Grant for Research in Oncology; Miguel Servet Fellowship and Grant Award (MS16/00112 and CP16/00112) and Project PI18/00816 within the Health Strategic Action from the ISCIII (to A.O.-M.), both cofunded by the European Regional Development Fund, Marcos Fernandez Fellowship from the Spanish Leukaemia and Lymphoma Foundation/Vistare Foundation (to A.O.-M.) and L'Oreal For Women in Science Award (to A.O.-M.). J.F. is a recipient of a Cancer Research UK Programme Award (15968) and J.O. is a recipient of a Cancer Research UK Clinician Scientist Fellowship (22742). N.M.-M. is a Ramon y Cajal Awardee MICIU/AEI (RYC-2016-20173). N.D.-S., C.C.A., A.B.P.-G. and K.T. are recipients of Ayudas de contratos predoctorales para la formacion de doctores from MICIU/AEI (BES-2016-077410, BES-2015-073776, BES-2017-081381, BES-2016-078082).
dc.description.abstractThe humoral immune response demands that B cells undergo a sudden anabolic shift and high cellular nutrient levels which are required to sustain the subsequent proliferative burst. Follicular lymphoma (FL) originates from B cells that have participated in the humoral response, and 15% of FL samples harbor point, activating mutations in , an essential activator of mTORC1 downstream of the sensing of cellular nutrients. The impact of recurrent mutations in B cell function and lymphoma is unexplored. mutations, targeted to the endogenous locus in mice, confer a partial insensitivity to nutrient deprivation, but strongly exacerbate B cell responses and accelerate lymphomagenesis, while creating a selective vulnerability to pharmacological inhibition of mTORC1. This moderate increase in nutrient signaling synergizes with paracrine cues from the supportive T cell microenvironment that activates B cells via the PI3K-Akt-mTORC1 axis. Hence, mutations sustain induced germinal centers and murine and human FL in the presence of decreased T cell help. Our results support a model in which activating mutations in the nutrient signaling pathway foster lymphomagenesis by corrupting a nutrient-dependent control over paracrine signals from the T cell microenvironment.
dc.format.number8
dc.format.page775-789
dc.format.volume1
dc.identifier.citationNat Metab . 2019 Aug;1(8):775-789.
dc.identifier.journalNat Metab
dc.identifier.pmchttps://pmc.ncbi.nlm.nih.gov/articles/PMC6774795/pdf/EMS84435.pdf
dc.identifier.pubmedID31579886
dc.identifier.urihttps://hdl.handle.net/20.500.12105/26224
dc.language.isoeng
dc.publisherNature Publishing Group
dc.relation.projectIDinfo:eu-repo/grantAgreement/MINECO//SAF2015-67538-R/ES/LA FISIOLOGIA DEL SENSADO Y SENALIZACION DE NUTRIENTES POR EL COMPLEJO 1 DE MTOR/
dc.relation.projectIDS
dc.relation.publisherversionhttps://doi: 10.1038/s42255-019-0098-8.
dc.repisalud.institucionCNIO
dc.repisalud.orgCNIOCNIO::Grupos de investigación::Grupo de Metabolismo y Señalización Celular
dc.rights.accessRightsopen access
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectB cell lymphoma
dc.subjectB lymphocytes
dc.subjectRRAGC
dc.subjectT follicular helper
dc.subjectapoptosis
dc.subjectcell growth
dc.subjectgerminal center
dc.subjectmTOR
dc.subjectnutrient signaling
dc.subjectrapamycin
dc.titleOncogenic Rag GTPase signaling enhances B cell activation and drives follicular lymphoma sensitive to pharmacological inhibition of mTOR.
dc.typeresearch article
dc.type.hasVersionAM
dspace.entity.typePublication
relation.isAuthorOfPublicationfa895eb1-39d5-447c-9b8c-314f35de09c9
relation.isAuthorOfPublicationfa895eb1-39d5-447c-9b8c-314f35de09c9
relation.isAuthorOfPublication.latestForDiscoveryfa895eb1-39d5-447c-9b8c-314f35de09c9

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
oncogenicragtpase-2019.pdf
Size:
2.99 MB
Format:
Adobe Portable Document Format